Thornburg Investment Management Inc Abb Vie Inc. Transaction History

Thornburg Investment Management Inc

$7.17 Billion
Q3 2024

A detailed history of Thornburg Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Thornburg Investment Management Inc holds 812,375 shares of ABBV stock, worth $143 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares

812,375

Previous 807,598 0.59%

Holding current value

$143 Million

Previous $139 Million 15.82%

% of portfolio

2.24%

Previous 2.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$163.84 - $199.33 $782,663 - $952,199	4,777 Added 0.59%	812,375 $160 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $31.5 Million - $35.9 Million	-197,107 Reduced 19.62%	807,598 $147 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $265,020 - $329,800	2,000 Added 0.2%	1,004,705 $135 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $11.1 Million - $12.8 Million	-76,879 Reduced 7.12%	1,002,705 $160 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $42.5 Million - $50.9 Million	-307,163 Reduced 22.15%	1,079,584 $175 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $167 Million - $191 Million	-1,243,301 Reduced 47.27%	1,386,747 $186 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $16.9 Million - $21.5 Million	-122,659 Reduced 4.46%	2,630,048 $403 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $95.6 Million - $119 Million	-724,519 Reduced 20.84%	2,752,707 $446 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $6.74 Million - $8.52 Million	-62,705 Reduced 1.77%	3,477,226 $471 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $12.4 Million - $14.1 Million	116,341 Added 3.4%	3,539,931 $382 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $3.28 Million - $3.65 Million	-31,178 Reduced 0.9%	3,423,590 $386 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $193,244 - $212,739	1,889 Added 0.05%	3,454,768 $374 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $20.6 Million - $27.8 Million	-255,389 Reduced 6.89%	3,452,879 $370 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $2.37 Million - $2.79 Million	-27,637 Reduced 0.74%	3,708,268 $325 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $21.3 Million - $28.5 Million	289,896 Added 8.41%	3,735,905 $367 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $45.5 Million - $69 Million	705,697 Added 25.75%	3,446,009 $263 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $251,373 - $314,521	3,485 Added 0.13%	2,740,312 $243 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $114 Million - $136 Million	1,802,197 Added 192.82%	2,736,827 $207 Million
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $61.4 Million - $78.5 Million	934,630 New	934,630 $68 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.

Account

Thornburg Investment Management Inc Abb Vie Inc. Transaction History